Novabay Pharmaceuticals, Inc.盘中异动大幅下挫5.91%

自选股智能写手04-18

北京时间2024年04月18日21时53分，Novabay Pharmaceuticals, Inc.（NBY.us）股票出现波动，股价快速下跌5.91%。截至发稿，该股报0.078美元/股，成交量186.951万股，换手率6.21%，振幅3.86%。最近的财报数据显示，该股实现营业收入14.73百万美元，净利润-9.64百万美元，每股收益-3.96美元，毛利7.90百万美元，市盈率-0.02倍。...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2428594038?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-04-18 21:53","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2428594038","market":"us","top_or_hot":-1,"title":"Novabay Pharmaceuticals, Inc.盘中异动 大幅下挫5.91%","media":"自选股智能写手","content":"<div>\n<p>北京时间2024年04月18日21时53分，Novabay Pharmaceuticals, Inc.（NBY.us）股票出现波动，股价快速下跌5.91%。截至发稿，该股报0.078美元/股，成交量186.951万股，换手率6.21%，振幅3.86%。最近的财报数据显示，该股实现营业收入14.73百万美元，净利润-9.64百万美元，每股收益-3.96美元，毛利7.90百万美元，市盈率-0.02倍。...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041821530379219061&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novabay Pharmaceuticals, Inc.盘中异动 大幅下挫5.91%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovabay Pharmaceuticals, Inc.盘中异动 大幅下挫5.91%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-04-18 21:53 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041821530379219061&s=b><strong>自选股智能写手</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2024年04月18日21时53分，Novabay Pharmaceuticals, Inc.（NBY.us）股票出现波动，股价快速下跌5.91%。截至发稿，该股报0.078美元/股，成交量186.951万股，换手率6.21%，振幅3.86%。最近的财报数据显示，该股实现营业收入14.73百万美元，净利润-9.64百万美元，每股收益-3.96美元，毛利7.90百万美元，市盈率-0.02倍。...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041821530379219061&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4007","symbol_name":"制药","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041821530379219061&s=b","article_id":"2428594038","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041821530379219061&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2428594038","pubTimestamp":1713448383,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2024年04月18日21时53分，Novabay Pharmaceuticals, Inc.股票出现波动，股价快速下跌5.91%。Novabay Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.62%。其相关个股中，Bio-Path Holdings, Inc.、Aileron Therapeutics, Inc.、Tiziana Life Sciences Ltd涨幅较大，Bio-Path Holdings, Inc.、Benitec Biopharma Inc.、Soligenix, Inc.较为活跃，换手率分别为3630.19%、65.63%、27.74%，振幅较大的相关个股有Bio-Path Holdings, Inc.、Aileron Therapeutics, Inc.、Prokidney Corp.，振幅分别为66.05%、34.82%、29.11%。Novabay Pharmaceuticals, Inc.公司简介：NovaBay Pharmaceuticals Inc是一家生物制药公司，开发和销售科学创造并经过临床验证的眼部护理和护肤产品。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4007":"制药","NBY":"NovaBay Pharmaceuticals Inc"},"translate_title":"Novabay Pharmaceuticals, Inc. fell 5.91% in intraday changes","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NBY":0.9},"content_text":"北京时间2024年04月18日21时53分，Novabay Pharmaceuticals, Inc.（NBY.us）股票出现波动，股价快速下跌5.91%。截至发稿，该股报0.078美元/股，成交量186.951万股，换手率6.21%，振幅3.86%。最近的财报数据显示，该股实现营业收入14.73百万美元，净利润-9.64百万美元，每股收益-3.96美元，毛利7.90百万美元，市盈率-0.02倍。机构评级方面，在所有2家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。Novabay Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.62%。其相关个股中，Bio-Path Holdings, Inc.、Aileron Therapeutics, Inc.、Tiziana Life Sciences Ltd涨幅较大，Bio-Path Holdings, Inc.、Benitec Biopharma Inc.、Soligenix, Inc.较为活跃，换手率分别为3630.19%、65.63%、27.74%，振幅较大的相关个股有Bio-Path Holdings, Inc.、Aileron Therapeutics, Inc.、Prokidney Corp.，振幅分别为66.05%、34.82%、29.11%。Novabay Pharmaceuticals, Inc.公司简介：NovaBay Pharmaceuticals Inc是一家生物制药公司，开发和销售科学创造并经过临床验证的眼部护理和护肤产品。其主导产品Avenova抗微生物眼睑和睫毛液(Avenova Spray)在实验室测试中被证明具有广泛的抗菌性能，因为它可以清除包括眼睑在内的眼部周围皮肤上的微生物和碎片等外来物质。Avenova Spray 可通过在线分销渠道直接向消费者提供，并且还经常由眼科护理专业人员开具处方和配药，用于治疗睑缘炎和干眼症。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2428594038"}

Novabay Pharmaceuticals, Inc.盘中异动 大幅下挫5.91%

精彩评论

Novabay Pharmaceuticals, Inc.盘中异动大幅下挫5.91%